RedStroke - Reducing Europe's Stroke Incidence
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 1019 participants.
Also called NCT04108884
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; triple masking; primary purpose screening
- Phase
- Not applicable
- Enrolled
- 1,019 participants
- Registry
-
NCT04108884
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Germany, Greece, Hungary, Netherlands, Poland, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT04108884. Randomized; triple masking; primary purpose screening. Start 2019-10-22 (actual); primary completion 2024-01-18 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- RedStroke - Reducing Europe's Stroke Incidence
- Acronym
- RedStroke
- Condition
- Atrial Fibrillation
- Intervention (Device)
- App measurement
- Intervention (Device)
- 14 day Holter ECG
- Lead sponsor
- University Hospital, Basel, Switzerland
- Collaborator
- European Union
- Collaborator
- Preventicus GmbH
Record details
- Record id
cardio:ct-nct04108884- Content hash
d0f3c954257a670fa798dc46bb29d537d97d30b7576d7da71b72703ed33abba9